Status:

COMPLETED

PACAP38 Induced Headache and Rosacea-like Symptoms in Patients With Rosacea

Lead Sponsor:

Danish Headache Center

Conditions:

Rosacea

Eligibility:

All Genders

18-60 years

Phase:

NA

Brief Summary

The investigators aim is to investigate the incidence of headache and rosacea-like flushing after pituitary adenylate cyclase-activating peptide-38 (PACAP38) with and without treatment with sumatripta...

Detailed Description

Pituitary adenylate cyclase-activating peptide-38 (PACAP38) plays a role in rosacea pathophysiology. Infusions of PACAP38 can trigger migraine-like attacks in migraine patients. PACAP38 also induces f...

Eligibility Criteria

Inclusion

  • diagnosed with rosacea
  • weight between 50 - 100 kilograms
  • women in fertile age must not be pregnant and must use adequate contraception

Exclusion

  • migraine more than 5 days per month in average over the past year
  • any primary headache other than migraine, apart from tension-type headache which must be less than 5 days per month
  • headache \< 48 hours before experimental day
  • migraine \< 72 hours before each experimental day
  • daily / frequent use of any medication apart from contraceptive medication
  • use of any drug less than 5 times the half-life of the drug at the time of the experiment
  • women who are pregnant or breast-feeding at the time of the experiment
  • anamnestic or clinical signs of hypertension (systolic blood pressure \> 150 mmHg and/or diastolic blood pressure \> 100 mmHg) or hypotension (systolic blood pressure \< 90 mmHg and/or diastolic blood pressure \< 50 mmHg)
  • anamnestic or clinical signs of mental illness, or abuse of alcohol / drugs
  • patients with glaucoma or prostate hyperplasia
  • anamnestic or clinical symptoms of any sort that the investigating doctor deemed unfit for participating in the study

Key Trial Info

Start Date :

November 12 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 19 2019

Estimated Enrollment :

38 Patients enrolled

Trial Details

Trial ID

NCT03878784

Start Date

November 12 2018

End Date

December 19 2019

Last Update

March 26 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

DanishHC

Glostrup Municipality, Denmark, DK-2600